Analysis of biological characteristic features in cancer stem cell in digestive organs
消化器官肿瘤干细胞生物学特性分析
基本信息
- 批准号:20590809
- 负责人:
- 金额:$ 2.91万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2008
- 资助国家:日本
- 起止时间:2008 至 2010
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Cancer related materials, i.e., cell lines, endoscopic biopthy specimen, or, surgically resected specimen, were analyzed for ; i) expression of cancer stem cell markers, ii) tumor formation, iii) colony forming activity, iv) drug-resistance, and v) potentials for local invasion and metastasis. Our results suggest that side population (SP) cells isolated from pancreatic cancer have some cancer stem cell-like properties ; i) high tumorigenic/colony forming activity, ii) resistance to some chemotherapeutic drugs as well as apoptosis-inducing molecules such as TRAIL, iii) high metstatic potential, and iv) enhanced capability to undergo epithelial-to-mesenchymal transition (EMT) and invasion. In hepatocellular carcinoma, CD133-positive side population cells were highly tumorigenic and chemotherapy-resistant. These cancer stem cell-like features were enhanced by co-culturing with bone marrow-derived mesenchymal stem cells (MSCs) and/or MSC-derived myofibroblast-like cells, suggesting MSCs provide microenvironment so-called cancer stem cell niche to maintain stem cell phenotype in cancer derived SP cells. These results suggest that SP cells would be a therapeutic tagrget, especially to prevent cancer sten cell invasion and metastasis. Mesenchymal cell-derived microenvironment would be another terapeutic target to regulate cancer stem cell maintenance.
癌症相关材料,即,分析细胞系、内窥镜活检样本或手术切除样本的:i)癌症干细胞标志物的表达,ii)肿瘤形成,iii)集落形成活性,iv)耐药性,和v)局部侵袭和转移的可能性。我们的研究结果表明,从胰腺癌中分离的侧群(SP)细胞具有一些癌症干细胞样特性; i)高致瘤性/集落形成活性,ii)对某些化疗药物以及肿瘤诱导分子(如TRAIL)的抗性,iii)高转移潜力,以及iv)增强的经历上皮向间充质转化(EMT)和侵袭的能力。在肝细胞癌中,CD 133阳性侧群细胞具有高度致瘤性和化疗耐药性。这些癌症干细胞样特征通过与骨髓来源的间充质干细胞(MSC)和/或MSC来源的肌纤维母细胞样细胞共培养而增强,这表明MSC提供了所谓的癌症干细胞小生境的微环境以维持癌症来源的SP细胞中的干细胞表型。提示SP细胞有可能成为一种治疗靶点,特别是在预防肿瘤干细胞侵袭和转移方面。间充质细胞来源的微环境将是调节肿瘤干细胞维持的另一个靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8
- DOI:10.1111/j.1349-7006.2010.01565.x
- 发表时间:2010-06-01
- 期刊:
- 影响因子:5.7
- 作者:Kurita, Satoshi;Higuchi, Hajime;Hibi, Toshifumi
- 通讯作者:Hibi, Toshifumi
Side population of pancreatic cancer cells predominates in TGF-beta-me diated epithelial to mesenchymal transition and invasion
胰腺癌细胞的侧群在 TGF-β 介导的上皮间质转化和侵袭中占主导地位
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Kabashima A;et al.
- 通讯作者:et al.
Wnt signaling contributes to the maintenance of cancer stem cell-like populations in Huh7 hepatocellular carcinoma cell line : Role of hepatic stellate cells.
Wnt 信号传导有助于 Huh7 肝细胞癌细胞系中癌症干细胞样群的维持:肝星状细胞的作用。
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Masayuki Adachi;Hajime Higuchi;Ayano Kabashima;Shinsuke Funakoshi;Shoko Nakamura;Hiromasa Takaishi;Toshifumi Hibi
- 通讯作者:Toshifumi Hibi
Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion.
胰腺癌细胞的侧群在 TGF-β 介导的上皮间质转化和侵袭中占主导地位。
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Ayano Kabashima;Hajime Higuchi;Hiromasa Takaishi;Yumi Matsuzaki;Sadafumi Suzuki;Motoko Izumiya;Hideko Iizuka;Gen Sakai;Shigenari Hozawa;Toshifumi Azuma;Toshifumi Hibi
- 通讯作者:Toshifumi Hibi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HIGUCHI Hajime其他文献
HIGUCHI Hajime的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HIGUCHI Hajime', 18)}}的其他基金
Analysis of mechanisms of apoptosis resistance in pancreatic cancer cells
胰腺癌细胞抗凋亡机制分析
- 批准号:
18590745 - 财政年份:2006
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of Interferon Responsive Apoptosis Regulating Genes in Hepatocellular Carcinoma
肝细胞癌中干扰素反应性细胞凋亡调节基因的鉴定
- 批准号:
16590632 - 财政年份:2004
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Roles of E2F3 and SGO1 in the Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
E2F3和SGO1在乳腺癌上皮间质转化和转移中的作用
- 批准号:
9911351 - 财政年份:2019
- 资助金额:
$ 2.91万 - 项目类别:
Fibronectin Mechanics and Signaling in Epithelial to Mesenchymal Transition
上皮间质转化中的纤连蛋白力学和信号传导
- 批准号:
9318153 - 财政年份:2016
- 资助金额:
$ 2.91万 - 项目类别:
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer
靶向乳腺癌中上皮间质转化介导的化疗耐药性
- 批准号:
9267438 - 财政年份:2016
- 资助金额:
$ 2.91万 - 项目类别:
Fibronectin Mechanics and Signaling in Epithelial to Mesenchymal Transition
上皮间质转化中的纤连蛋白力学和信号传导
- 批准号:
9195389 - 财政年份:2016
- 资助金额:
$ 2.91万 - 项目类别:
Targeting the epithelial to mesenchymal transition-mediated chemoresistance in breast cancer
靶向乳腺癌中上皮间质转化介导的化疗耐药性
- 批准号:
9891022 - 财政年份:2016
- 资助金额:
$ 2.91万 - 项目类别:
Epithelial to Mesenchymal Transition and Fibrosis in Inflammatory Bowel Disease
炎症性肠病中的上皮间质转化和纤维化
- 批准号:
8111479 - 财政年份:2011
- 资助金额:
$ 2.91万 - 项目类别:
Epithelial to Mesenchymal Transition and Fibrosis in Inflammatory Bowel Disease
炎症性肠病中的上皮间质转化和纤维化
- 批准号:
8912450 - 财政年份:2011
- 资助金额:
$ 2.91万 - 项目类别:
Epithelial to Mesenchymal Transition and Fibrosis in Inflammatory Bowel Disease
炎症性肠病中的上皮间质转化和纤维化
- 批准号:
8261681 - 财政年份:2011
- 资助金额:
$ 2.91万 - 项目类别:
Epithelial to Mesenchymal Transition and Fibrosis in Inflammatory Bowel Disease
炎症性肠病中的上皮间质转化和纤维化
- 批准号:
8663888 - 财政年份:2011
- 资助金额:
$ 2.91万 - 项目类别:
Epithelial to Mesenchymal Transition and Fibrosis in Inflammatory Bowel Disease
炎症性肠病中的上皮间质转化和纤维化
- 批准号:
8457090 - 财政年份:2011
- 资助金额:
$ 2.91万 - 项目类别: